fr en es de it pt nl

Reagents and instruments for immunology, cell biology and molecular biology.

Search result : 15 product found

Refine your search :

RUOCE / IVD

Unconjugated 3

human 4

kit 5
ELISA/ELISPOT 4
Biochemicals 3
Inhibitor/Antagonist/Agonist 3

ELISA 4

APPLY FILTERS
REINITIALIZE

Cat#

Description

Cond.

Price Bef. VAT

orb1910863-100mg

BAY-2965501 is a first-in-class a diacylglycerol kinase zeta (DGKζ, lipid kinase) inhibitor with IC50 of 27 nM/35 nM (human/mouse) and shows > 20-fold selectivity for DGKζ over other DGK isotypes. BAY-2965501 blocks DGKζ in T-cells to activate them [[2732902-08-6]]

100mg

orb1910863-250mg

BAY-2965501 is a first-in-class a diacylglycerol kinase zeta (DGKζ, lipid kinase) inhibitor with IC50 of 27 nM/35 nM (human/mouse) and shows > 20-fold selectivity for DGKζ over other DGK isotypes. BAY-2965501 blocks DGKζ in T-cells to activate them [[2732902-08-6]]

250mg

orb1910863-1g

BAY-2965501 is a first-in-class a diacylglycerol kinase zeta (DGKζ, lipid kinase) inhibitor with IC50 of 27 nM/35 nM (human/mouse) and shows > 20-fold selectivity for DGKζ over other DGK isotypes. BAY-2965501 blocks DGKζ in T-cells to activate them [[2732902-08-6]]

1g

MBS109733-48

Qualitative Human T-Cell Lymphotropic Virus Types I and II P19 Antigen (HTLV-I/II-P19) ELISA Kit

48-Strip-Wells

MBS109733-10x96

Qualitative Human T-Cell Lymphotropic Virus Types I and II P19 Antigen (HTLV-I/II-P19) ELISA Kit

10x96-Strip-Wells

MBS109733-96

Qualitative Human T-Cell Lymphotropic Virus Types I and II P19 Antigen (HTLV-I/II-P19) ELISA Kit

96-Strip-Wells

MBS109733-5x96

Qualitative Human T-Cell Lymphotropic Virus Types I and II P19 Antigen (HTLV-I/II-P19) ELISA Kit

5x96-Strip-Wells

orb1911024-1g

Mezigdomide is a cereblon E3 ubiquitin ligase modulating agent with potential immunomodulating and antineoplastic activities. Mezigdomide specifically binds to cereblon (CRBN), thereby affecting the ubiquitin E3 ligase activity, and targeting certain substrate proteins for ubiquitination. This induces proteasome-mediated degradation of certain transcription factors, some of which are transcriptional repressors in T cells. This leads to modulation of the immune system, including activation of T lymphocytes, and downregulation of the activity of other proteins, some of which play key roles in the proliferation of certain cancer cell types. [[2259648-80-9]]

1g

orb1911024-250mg

Mezigdomide is a cereblon E3 ubiquitin ligase modulating agent with potential immunomodulating and antineoplastic activities. Mezigdomide specifically binds to cereblon (CRBN), thereby affecting the ubiquitin E3 ligase activity, and targeting certain substrate proteins for ubiquitination. This induces proteasome-mediated degradation of certain transcription factors, some of which are transcriptional repressors in T cells. This leads to modulation of the immune system, including activation of T lymphocytes, and downregulation of the activity of other proteins, some of which play key roles in the proliferation of certain cancer cell types. [[2259648-80-9]]

250mg

orb1911024-100mg

Mezigdomide is a cereblon E3 ubiquitin ligase modulating agent with potential immunomodulating and antineoplastic activities. Mezigdomide specifically binds to cereblon (CRBN), thereby affecting the ubiquitin E3 ligase activity, and targeting certain substrate proteins for ubiquitination. This induces proteasome-mediated degradation of certain transcription factors, some of which are transcriptional repressors in T cells. This leads to modulation of the immune system, including activation of T lymphocytes, and downregulation of the activity of other proteins, some of which play key roles in the proliferation of certain cancer cell types. [[2259648-80-9]]

100mg

CTI.SDK.4

Single Donor Kit - 4 CELL TYPES

1Kit

CTI.SDK.6

Single Donor Kit - 6 CELL TYPES

1Kit

CTI.SDK.5

Single Donor Kit - 5 CELL TYPES

1Kit

CTI.SDK.2

CTISkin® Single Donor Kit - 2 CELL TYPES

1Kit

CTI.SDK.3

CTISkin® Single Donor Kit - 3 CELL TYPES

1Kit

‹

›